Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$3.31
▾0.08 (2.36%)
Last trade: 28/09, 8:16PM
Market cap
$281.60m
Market closed
Talk to Mayne Pharma Group Limited directly.
Sign up to their Investor Hub for direct access to the Mayne Pharma Group Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Address
1538 Main N Rd, Salisbury South SA 5106, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$3.31
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2023 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2023 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.